Trial Profile

VP-VLY-686-1301: A Single Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying in Healthy Volunteers

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 19 Apr 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tradipitant (Primary)
Indications Atopic dermatitis; COVID 2019 infections; Gastroparesis; Motion sickness; Pruritus
Focus Pharmacodynamics
Sponsors Vanda Pharmaceuticals

19 Mar 2024 Status changed from recruiting to completed.
29 May 2022 Primary endpoint (Gastric emptying half-time of solids as measured by scintigraphy) has not been met according to the results published in the Alimentary Pharmacology and Therapeutics
29 May 2022 Primary endpoint (Satiation expressed as volume to fullness as measured by satiation test) has not been met according to the results published in the Alimentary Pharmacology and Therapeutics

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com